Position in OMER
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,097,149
-$71,103 QoQ
Shares Held
115,368
+4.3% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Derivatives in OMER
reported options exposure · as of Jun 30, 2020CallValue
$7,360
CallShares
500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. OMER ranks #27 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,551 | $82,484,707 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
64,650 | $40,311,861 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,045 | $31,621,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,020 | $24,349,704 | |
| 5 | RPRX |
Royalty Pharma plc
|
285,630 | $16,015,274 | |
| 6 | EXEL |
Exelixis, Inc.
|
291,162 | $15,842,124 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
56,313 | $13,783,733 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
140,394 | $11,443,514 |
All Filings in OMER
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,097,149 | 115,368 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,168,252 | 110,630 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,787,733 | 104,059 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $390,254 | 95,184 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $207,552 | 69,184 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $495,986 | 60,339 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $586,269 | 59,339 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $235,575 | 59,339 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $224,676 | 55,339 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $190,919 | 55,339 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $184,228 | 56,339 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $202,469 | 69,339 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $355,444 | 65,339 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $271,276 | 58,339 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $118,286 | 52,339 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $166,285 | 52,789 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $128,119 | 46,589 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $222,904 | 37,089 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $228,998 | 35,614 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $473,190 | 34,314 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $479,539 | 32,314 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $576,844 | 32,407 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $470,955 | 32,957 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $333,781 | 33,015 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,360 | 500 | Call | Sole | 2020-08-10 | |
| 2020-06-30 | $441,820 | 30,015 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $375,229 | 28,065 | Shares | Sole | 2020-05-21 | |
| 2020-03-31 | $6,685 | 500 | Call | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||